20 Results for "

Angioedema

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "Angioedema" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-16735
CAS No.: 918407-35-9
Synonyms: BCX4161
Target:  

Kallikrein

Research Areas:  

Others

Avoralstat (BCX4161), a potent and orally active plasma kallikrein (PKK) inhibitor, is used for hereditary angioedema research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99631
CAS No.: 2162134-62-3
Synonyms: CSL312

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108814A
Purity:  97.69%
Synonyms: DX-88 TFA
Target:  

Kallikrein

Research Areas:  

Cardiovascular Disease

Ecallantide (DX-88) TFA is a specific recombinant plasma kallikrein inhibitor. Ecallantide inhibits the production of bradykinin. Ecallantide may be used to prevent acute attacks of angioedema .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109127
CAS No.: 1809010-50-1
Purity:  98.12%
Synonyms: BCX7353
Target:  

Kallikrein

Research Areas:  

Cardiovascular Disease Cancer

Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109127A
CAS No.: 1809010-52-3
Purity:  98.49%
Synonyms: BCX7353 dihydrochloride
Target:  

Kallikrein

Research Areas:  

Cardiovascular Disease Cancer

Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
Cat. No.: HY-P99110
CAS No.: 1426055-14-2
Synonyms: SHP643; DX-2930; X124-G01

Target:  

Kallikrein

Research Areas:  

Inflammation/Immunology

Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema .
loading...
    loading...
Cat. No.: HY-139787
CAS No.: 2304692-48-4
Synonyms: ISIS-721744 free acid; IONIS-PKK-LRX free acid
Donidalorsen (ISIS-721744; IONIS-PKK-LRX free acid) is an antisense oligonucleotide targeting prekallikrein (PKK). Donidalorsen inhibits kallikrein activity and reduces the production of Bradykinin (HY-P0206) by specifically binding to and degrading PKK mRNA in the liver. Donidalorsen can be used in the research of hereditary angioedema .
loading...
    loading...
Cat. No.: HY-139787A
CAS No.: 2304701-45-7
Synonyms: ISIS-721744; IONIS-PKK-LRX
Donidalorsen (ISIS-721744; IONIS-PKK-LRX) sodium is an antisense oligonucleotide targeting prekallikrein (PKK). Donidalorsen sodium inhibits kallikrein activity and reduces the production of Bradykinin (HY-P0206) by specifically binding to and degrading PKK mRNA in the liver. Donidalorsen sodium can be used in the research of hereditary angioedema .
loading...
    loading...
Cat. No.: HY-P991629

Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

C1 Esterase Inhibitor (Human) is a C1 Esterase inhibitor derived from human plasma. C1 Esterase Inhibitor (Human), a glycoprotein, is a serum protease inhibitor (serpin) that binds covalently and inactivates C1r, C1s, and mannan-binding protein-associated proteases (MASPs). C1 Esterase Inhibitor (Human) has anti-inflammatory effects. C1 Esterase Inhibitor (Human) can be used to prevent angioedema attacks associated with hereditary angioedema .
loading...
    loading...
Cat. No.: HY-126378
CAS No.: 1801253-04-2
Purity:  99.05%
Target:  

Kallikrein

Research Areas:  

Inflammation/Immunology

LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell .
loading...
    loading...
Cat. No.: HY-108814
CAS No.: 460738-38-9
Synonyms: DX-88
Target:  

Kallikrein

Research Areas:  

Cardiovascular Disease

Ecallantide (DX-88) is a specific plasma kallikrein inhibitor. Ecallantide inhibits the production of bradykinin. Ecallantide can be used to prevent acute attacks of angioedema .
loading...
    loading...
Cat. No.: HY-150052
CAS No.: 1357950-47-0
Target:  

Kallikrein

Plasma kallikrein-IN-3 is a plasma kallikrein inhibitor (IC50: 0.15 μM). Plasma kallikrein-IN-3 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research .
loading...
    loading...
Cat. No.: HY-143476
Target:  

Kallikrein

Plasma kallikrein-IN-2 (Compound 198) is a potent plasma kallikrein (PKal) inhibitor with an IC50 of 0.1 nM. Plasma kallikrein-IN-2 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research .
loading...
    loading...
Cat. No.: HY-163464
Target:  

Kallikrein

Research Areas:  

Cardiovascular Disease

Plasma kallikrein-IN-5 (Compound 20) is a potent covalent inhibitor of plasma potassium kinin peptide (Pka) with IC50 values of 66 nM and 70 pM at 1 minute and 24 hours, respectively. Plasma kallikrein-IN-5 can be used IN the study of hereditary angioedema (HAE) .
loading...
    loading...
Cat. No.: HY-114412A
CAS No.: 1073549-11-7
Purity:  98.44%
TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP .
loading...
    loading...
Cat. No.: HY-114412
CAS No.: 1073549-10-6
TD-0212 (compound 35) is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP .
loading...
    loading...
Cat. No.: HY-109127R
CAS No.: 1809010-50-1
Synonyms: BCX7353 (Standard)
Berotralstat (Standard) is the analytical standard of Berotralstat. This product is intended for research and analytical applications. Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema.
loading...
    loading...
Cat. No.: HY-109127AR
CAS No.: 1809010-52-3
Synonyms: BCX7353 dihydrochloride (Standard)
Berotralstat dihydrochloride (Standard) is the analytical standard of Berotralstat (dihydrochloride) (HY-109127A). This product is intended for research and analytical applications. Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
Cat. No.: HY-P991994

Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

REGN9533 is a human-derived monoclonal antibody against FXII/FXIIa with high affinity for FXII, FXIIa and β-FXIIa. REGN9533 selectively inhibits the intrinsic coagulation pathway and FXIIa-driven plasma kallikrein activity. REGN9533 is applicable to FXIIa-related diseases such as thrombosis and hereditary angioedema .
loading...
    loading...
Cat. No.: HY-109127S
Synonyms: BCX7353-d4-1
Berotralstat-d4-1 (BCX7353-d4-1) is the deuterium labeled Berotralstat (HY-109127). Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema .
loading...
    loading...
  • 1